Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis

Scandinavian Journal of Urology and Nephrology

Volumn 19, Issue 1, 1985, Pages 55-57

  Grontoft K C ^a   Mulec, H ^b   Gutierrez, A ^a   Olander, R ^a  

^a Örebro ^*  (United States)

^b Centrallasarettet ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; TICLOPIDINE;

ADULT; ADVERSE DRUG REACTION; AGED; ARTERIOVENOUS FISTULA; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HUMAN; KIDNEY; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIORITY JOURNAL; THROMBOSIS PREVENTION; UREMIA;

ADULT; AGED; ANTICOAGULANTS; ARTERIOVENOUS SHUNT, SURGICAL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMAN; MALE; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; THIOPHENES; THROMBOSIS; TICLOPIDINE;

EID: 0021855136     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365598509180223     Document Type: Review

References (14)

1. Andrassy, K., Ritz, E., Schoeffner, W., Hahn, G. & Walter, K. 1971. The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients. Klin Wochenschr 23, 166.
2. Andrassy, K., Ritz, E., Hahn, G. & Buchholz, I. 1972. Klinische und experimentelle Untersuchungen bei rezidivierenden thrombotischen Verschluss von Scribner-Shunt bzw. Cimino-Fistel. In Aktuelle Pro-bleme der Dialyseverfahren und Niereninsuffizienz (ed. P. V. Dittrich & P. Skrabel), pp. 72-80. Binder-nagel, Freiburg.
3. Andrassy, K., Malluche, H., Bornefeld, H., Com-berg, M., Ritz, E., Jeschinsky, H. & Mohring, K. 1974. Prevention of p. o. clotting of av. Cimino fistulae with acetylsalicylic acid. Klin Wochenschr 52, 348.
4. Ashida, S., Sakuma, K. & Abiko, Y. 1980. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt models in rats. Thromb Res 17, 663.
5. Baenzinger, N. L. & Majorus, P. W. 1979. The mechanism of action of antiplatelet drugs. In Venous and arterial thrombosis (ed. J. H. Joist & L. A. Sherman), pp. 327. Grune and Stratton, New York.
6. Kaegi, A., Pineo, G. F., Shimizu, A., Trivedi, H., Hirch, J. & Gent, M. 1974. Arteriovenous shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med 290, 304.
7. Ketchen, L. D. 1978. Pharmacologic alteration in the clotting mechanism: use in microvascular surgery. J Hand Surg 3,405.
8. Moncada, S. & Korbut, R. 1978. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacycline. Lancet, 1286.
9. Mustard, J. F., Rowsell, H. C. & Smythe, H. A. 1967. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits. Blood 29, 859.
10. Mustard, J. F. & Packham, M. A. 1970. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev 22, 97.
11. O'Brien, J. R. 1968. Effects of salicylats on human platelets. Lancet, 779.
12. Panak, E., Maffrand, J. P., Picard-Fraire, C., Vallee, E., Blanchard, R. & Roncucci, R. 1983. Ticlopidine: A promise for the prevention and treatment of thrombosis and its complications. Haemostosis 13, Suppl. 1, pp. 1-54.
13. Pollak, V. E. 1970. Anticoagulants in the treatment of renal disease. Ann Intern Med 73, 334.
14. Ricotta, J. J., Schaff, H. V. & Gadacz, T. R. 1979. The effect of aspirin and dipyridamole on the patency of allograft veins. J Surg Res 26, 262.